The approval of ursodeoxycholic acid (UDCA) for primary biliary cholangitis (PBC) in 1997 marked a pivotal turning point in ...

November is Diabetic Eye Disease Awareness Month. Diabetes is the leading cause of preventable blindness in the US. Here is a ...

The rising popularity of appetite suppressant ‘obesity drugs’ is causing people to eat less when dining out. Is this a threat ...

Managing diabetes has come a long way, thanks to advancements in treatments and technologies that make life easier and ...

New research reveals that popular diabetes and weight-loss drugs may also protect the kidneys. This groundbreaking study, ...

But for a long time China’s people struggled to get hold of Wegovy because the country’s regulators had not approved it. Some ...

A SYSTEMATIC review investigating the impact of glucagon-like peptide-1 receptor agonists on alcohol consumption has yielded ...

Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle ...

Takers of GLP-1 are reportedly going on a "holiday pause" to enjoy meal centric family celebrations. Here, an MD breaks down ...

Berberine, green tea extract and taurine are just some of the ingredients advertised as being able to ‘boost’ GLP-1 levels.

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

Researchers at the University of Copenhagen have identified a signaling pathway that simultaneously increased energy expenditure and decreased food intake. In both human and primate studies, agonists ...